Evaluation of inhibitor reactivity might be a guide in the treatment of hemophilia A inhibitor patients

被引：0
|
作者：
Astermark, J
Lenk, H
Berntorp, E
机构：
[1] Dept Coagulat Disorders, Malmo, Sweden
[2] Univ Leipzig, Childrens Hosp, D-7010 Leipzig, Germany
来源：
THROMBOSIS AND HAEMOSTASIS | 1999年
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1489
引用
下载
收藏
页码：471 / 471
页数：1
相关论文
共 50 条
  • [31] Increased mortality risk in US Hemophilia A inhibitor patients
    Walsh, C.
    Soucie, M.
    Miller, C.
    HAEMOPHILIA, 2013, 19 (03) : 470 - 471
  • [32] Increased mortality risk in US Hemophilia A inhibitor patients
    Walsh, C.
    Miller, C. H.
    Soucie, M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 475 - 476
  • [33] Experience and Problems of Using Emicizumab in Hemophilia A Patients With Inhibitor
    Nagae, Chiai
    Mori, Mika
    Umezawa, Yotaro
    Sudo, Akina
    Tomoko, Ashikaga
    Oyama, Ryo
    Yamashita, Atsuki
    Mori, Tetsuya
    Taki, Masashi
    PEDIATRIC BLOOD & CANCER, 2019, 66 : S71 - S71
  • [34] Experience of total knee replacement for patients with hemophilia and inhibitor
    Zorenko, V.
    Polyanskaya, T.
    Karpov, E.
    HAEMOPHILIA, 2008, 14 : 53 - 53
  • [35] Genotype and inhibitor-development in hemophilia patients in Japan
    Nogami, Keiji
    Taki, Masashi
    Kojima, Tetsuhito
    Shinozawa, Keiko
    Fukutake, Katsuyuki
    Shima, Midori
    HAEMOPHILIA, 2016, 22 : 35 - 35
  • [36] Molecular genetics and inhibitor development in patients with hemophilia B
    Chuansumrit, A.
    Sasanakul, W.
    Sirachainan, N.
    Kadegasem, P.
    Wongwerawattanakoon, P.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 852 - 852
  • [37] Inhibitor surveillance and mutation analysis in hemophilia B patients
    Soucie, J. M.
    Creary, M.
    Abshire, T. C.
    Brettler, D. B.
    Bockenstedt, P. L.
    Di Paola, J.
    Massey, G.
    Neff, A. T.
    Shapiro, A. D.
    Tarantino, M.
    Wicklund, B. M.
    Manco-Johnson, M. J.
    Dunn, A. L.
    Knoll, C.
    Platt, S. J.
    Driggers, J.
    Ellingsen, D.
    Benson, J.
    Hooper, C.
    Miller, C. H.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 834 - 835
  • [38] Determinants of inhibitor development in previously treated hemophilia A patients
    Iorio, A.
    Barbara, A.
    Castaman, G.
    Fischer, K.
    Gilman, E.
    Goudemand, J.
    Kavakli, K.
    Kubicek-Hofmann, C.
    Lambert, T.
    Lissitchkov, T.
    Makris, M.
    Matthew, P.
    Castelano, M. E. M.
    Ozdemir, N.
    Parra, R.
    Peerlinck, K.
    Rivolta, G.
    Romanov, V
    Roussel-Robert, V
    Tagliaferri, A.
    Windyga, J.
    Zanon, E.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 149 - 149
  • [39] Inhibitor development in patients with mild hemophilia A: An Irish perspective
    Lavin, M.
    Jenkins, V.
    Ryan, K.
    O Donnell, J. .
    O connell, N.
    HAEMOPHILIA, 2012, 18 : 91 - 91
  • [40] The importance of inhibitor eradication in clinically complicated hemophilia A patients
    Oldenburg, Johannes
    Young, Guy
    Santagostino, Elena
    Ettingshausen, Carmen Escuriola
    EXPERT REVIEW OF HEMATOLOGY, 2018, 11 (11) : 857 - 862
12345